ozempic and other glp-1 drugs could reduce risk of cancer for diabetes patients, study says Why do so many people
Description
The guidance reductions and disappointing revenue were enough to set off investors, who punished Lilly with a selloff that sent shares tumbling 8% over two trading daysthe companys worst one-day stock decline since 2021
However, the path is now more unclear with the change in administration as well as continued stringent payor dynamics with respect to insurance coverage for obesity medications
2024;7:e2431997
We couldnt understand this, which is why we looked as many different ways as we could to see if this was a really robust observation, she said
